Srikripa Devarakonda's Stock Ratings

Truist Securities Analyst

Srikripa Devarakonda is an analyst at Truist Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024

Overall Average Return

2.32%

Smart Score

54.5%

Overall Average Return Percentile

43rd

Number of Ratings

33
Buy NowGet Alert
06/25/2024LLYBuy Now
Eli Lilly and Co
$906.0410.37%$892 → $1000ReiteratesBuy → BuyGet Alert
06/18/2024KROSBuy Now
Keros Therapeutics
$45.96117.58%$100 → $100MaintainsBuyGet Alert
05/29/2024CYTKBuy Now
Cytokinetics
$54.1829.2%$86 → $70MaintainsBuyGet Alert
05/01/2024INCYBuy Now
Incyte
$60.6236.92%$84 → $83ReiteratesBuy → BuyGet Alert
05/01/2024LLYBuy Now
Eli Lilly and Co
$906.04-1.55%$850 → $892MaintainsBuyGet Alert
04/17/2024EWTXBuy Now
Edgewise Therapeutics
$18.0538.5%$25 → $25MaintainsBuyGet Alert
04/08/2024CYTKBuy Now
Cytokinetics
$54.1858.73%$86 → $86ReiteratesBuy → BuyGet Alert
04/03/2024SRRKBuy Now
Scholar Rock Holding
$8.20143.9%$20 → $20ReiteratesBuy → BuyGet Alert
03/25/2024SRRKBuy Now
Scholar Rock Holding
$8.20143.9% → $20ReiteratesBuy → BuyGet Alert
03/13/2024KROSBuy Now
Keros Therapeutics
$45.96117.58% → $100ReiteratesBuy → BuyGet Alert
03/01/2024KYMRBuy Now
Kymera Therapeutics
$29.8580.9%$41 → $54MaintainsBuyGet Alert
02/14/2024INCYBuy Now
Incyte
$60.6238.57%$91 → $84MaintainsBuyGet Alert
12/28/2023CYTKBuy Now
Cytokinetics
$54.1858.73%$60 → $86MaintainsBuyGet Alert
11/29/2023INCYBuy Now
Incyte
$60.6250.12% → $91ReiteratesBuy → BuyGet Alert
11/15/2023VSTMBuy Now
Verastem
$2.991037.12%$39 → $34MaintainsBuyGet Alert
09/21/2023INCYBuy Now
Incyte
$60.6250.12% → $91ReiteratesBuy → BuyGet Alert
08/11/2023AFMDBuy Now
Affimed
$5.567.91%$80 → $60MaintainsBuyGet Alert
08/02/2023INCYBuy Now
Incyte
$60.6250.12%$100 → $91MaintainsBuyGet Alert
07/11/2023VSTMBuy Now
Verastem
$2.991204.35%$60 → $39MaintainsBuyGet Alert
06/30/2023KYMRBuy Now
Kymera Therapeutics
$29.8567.5% → $50Initiates → BuyGet Alert
06/28/2023EWTXBuy Now
Edgewise Therapeutics
$18.0538.5% → $25ReiteratesBuy → BuyGet Alert
06/27/2023VSTMBuy Now
Verastem
$2.991906.69%$60 → $60ReiteratesBuy → BuyGet Alert
06/27/2023EWTXBuy Now
Edgewise Therapeutics
$18.0538.5% → $25ReiteratesBuy → BuyGet Alert
06/23/2023VSTMBuy Now
Verastem
$2.991906.69% → $60ReiteratesBuy → BuyGet Alert
05/01/2023EWTXBuy Now
Edgewise Therapeutics
$18.0538.5% → $25Initiates → BuyGet Alert
03/20/2023NMTRBuy Now
9 Meters Biopharma
—— → $38DowngradeBuy → HoldGet Alert
02/16/2023INCYBuy Now
Incyte
$60.6264.96%$95 → $100MaintainsBuyGet Alert
12/20/2022CYTKBuy Now
Cytokinetics
$54.1810.74% → $60Initiates → BuyGet Alert
10/18/2022KROSBuy Now
Keros Therapeutics
$45.96117.58% → $100Initiates → BuyGet Alert
07/12/2022SRRKBuy Now
Scholar Rock Holding
$8.20143.9% → $20Initiates → BuyGet Alert
06/22/2022NMTRBuy Now
9 Meters Biopharma
——$100 → $40MaintainsBuyGet Alert
03/09/2022VSTMBuy Now
Verastem
$2.99100.67% → $72Initiates → BuyGet Alert
10/21/2021AFMDBuy Now
Affimed
$5.5679.86% → $100Initiates → BuyGet Alert